Philips signs agreement to create Taiwan’s first fully digitalized pathology department
August 22 2019 - 3:00AM
Philips signs agreement to create Taiwan’s first fully digitalized
pathology department
August 22, 2019
- Philips IntelliSite Pathology Solution adopted by Taiwan’s
leading academic medical and teaching center Taipei Veterans
General Hospital
- Philips IntelliSite Pathology Solution cleared for routine
primary diagnostic use in Taiwan
Amsterdam, the Netherlands and Taipei, Taiwan –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health
technology, today announced that Taipei Veterans General Hospital
(TPVGH) will utilize the Philips IntelliSite Pathology Solution to
transform its pathology tissue examination to digital diagnostics.
By allowing tissue samples to be remotely viewed within a virtual
pathology network across hospital locations, the Philips
IntelliSite Pathology Solution will help TPVGH to establish
Taiwan’s first fully digitalized pathology department, with the aim
of enhancing patient safety and improving the quality of diagnoses,
thereby leading to better patient outcomes.
Cancer is the leading cause of death in Taiwan. Pathology plays
a critical role in the detection and diagnosis of a wide variety of
diseases, including cancer. Tissue samples (biopsies) are examined
to determine if tissue cells are malignant and consequently to
guide treatment decisions. Speedy diagnosis and effective
personalized treatment have a significant impact on patients and
their families.
Pathological review of patient tissue has historically been done
using a microscope. Using the Philips IntelliSite Pathology
Solution with the Ultra-Fast Scanner (UFS), TPVGH will now be able
to digitize tissue samples so that pathologists can review,
interpret, analyze, and share digital images. The Image Management
System (IMS) that is part of the Philips IntelliSite Pathology
Solution allows them to instantly consult colleagues or
conveniently present images during multi-disciplinary team
meetings, without the need to physically transport pathology slides
or tissue samples.
“Philips Taiwan continues to help Taiwan in realizing
intelligent and advanced healthcare solutions,” said Richard Hu,
General Manager of Philips Taiwan. “Digitalizing pathology so that
tissue samples can be viewed remotely, wherever they are needed,
will not only enhance laboratory efficiency and quality but also
improve patient safety.” In addition to clinical use, the digital
images will be stored in image repositories and used to teach
pathology students, or used for medical research, including cancer
research.
Philips IntelliSite Pathology Solution is designed for in-vitro
diagnostic purposes, helping pathologists to review and interpret
digital images of surgical pathology slides prepared from
formalin-fixed paraffin-embedded (FFPE) tissue samples. It has
market access clearance in over fifty countries, including recent
market clearance in Taiwan.
For further information, please contact:
Joost MalthaPhilips Global Press OfficeTel. : +31 6 10 55
8116E-mail : joost.maltha@philips.com
Lilian ChaoPhilips TaiwanTel.: +88 6 2378 92282E-mail:
lilian.chao@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
enabling better outcomes across the health continuum from healthy
living and prevention, to diagnosis, treatment and home care.
Philips leverages advanced technology and deep clinical and
consumer insights to deliver integrated solutions. Headquartered in
the Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips generated 2018
sales of EUR 18.1 billion and employs approximately 78,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
- Digital pathology
- Philips Ultra Fast Scanner
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Sep 2023 to Sep 2024